Offer - Urjas Oil for just ₹ 1 X
Zuricab is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Acromegaly, Prolactinoma.
The optimal dosage of Zuricab is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Zuricab have been listed ahead. These side effects of Zuricab are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Zuricab is Mild for pregnant women and Severe for women who are breastfeeding. It is important to know if Zuricab has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Zuricab related warnings section.
Zuricab can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zuricab in conditions like High Blood Pressure, Heart Disease, Depression. Other conditions have been mentioned below in the Zuricab contraindications section.
Drug interactions for Zuricab have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Zuricab is considered not safe while driving, and is not addictive.
Zuricab is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Zuricab safe for pregnant women?
Zuricab has little to no side effects in pregnant women.
Is the use of Zuricab safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Zuricab. It should only be taken after medical advice.
What is the effect of Zuricab on the Kidneys?
Kidney can be affected by Zuricab. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Zuricab on the Liver?
Zuricab may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Zuricab on the Heart?
The heart can be affected by Zuricab. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Zuricab should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Zuricab unless your doctor advises you to do so -
Is this Zuricab habit forming or addictive?
Zuricab does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Zuricab you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Zuricab only as per medical advice.
Is it able to treat mental disorders?
No, Zuricab cannot treat any kind of mental disorder.
Interaction between Food and Zuricab
Due to a lack of research, nothing can be said about the consequences of taking Zuricab together with food.
Interaction between Alcohol and Zuricab
Taking Zuricab and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)